The Indian pharmaceutical market has for the first time crossed the Rs 100000 crore

MUMBAI: The Indian pharmaceutical market has for the first time crossed the Rs 100000 crore mark in November when calculated on the basis of Moving Annual Total (MAT), said IMS Health, a global pharmaceutical market research firm.

In its monthly review of the local market, IMS Health said in its note titled Market Reflections that Indian companies took over three-fourth of the market share during the month.

On an average over the last three years, Indian pharmaceutical market has grown by 12%. Almost 38% of the market was dominated by drugs that treat infections, heart ailments and patients with gastro-intestinal issues. IMS report said in November, Indian market was at Rs 100115 crore, of which the retail sector was valued at Rs 84279 crore.

Sun Pharma remained at the top of the list of drug companies with a market share of 8%, followed by Abbott with a share of 6.1%. Cipla trailed at 5.4% but grew higher than its top peers showing growth of 16% during the month. Mankind Pharma has jumped past its traditional rivals to secure the fourth position with a market share of 3.7%, standing above Alkem, GlaxoSmithKline and Zydus Cadila.

Mixtard, a popular insulin marketed by Abbott, continued to hold the position of the largest brand for the month followed by Pfizer cough syrup Corex and Glycomet-gp, a diabetes brand of USV.

http://articles.economictimes.indiatimes.com/2015-12-16/news/69090998_1_market-share-indian-companies-ims-health

India’s maiden med devices and pharma park to come up in Gujarat State

Gujarat government allots 60 acres for NIPER campus being set up at a cost of around Rs 500 crores

The Centre is mulling setting up the country’s maiden medical devices and pharma park in Gujarat in a bid to make India self-reliant in the sector. This was stated by Ananth Kumar, Union Minister of Chemicals and Fertilisers, who sought cooperation from the state government to implement these projects and the latter responded positively in terms of providing land for them.

According to Kumar, though India is doing well in manufacturing pharma products, it is still not self- reliant in the medical devices sector.

“This is an era of medical devices. But, even today, India is not self-reliant in producing these devices. Thus, we are planning to open first such medical devices park here in Gujarat if the government provides us cheaper land for it,” Kumar said in the presence of Anandiben Patel, Chief Minister, Gujarat.

The Gujarat government has alloted 60 acres for the campus being set up on Chiloda Road at a cost of around Rs 500 crores, stated an official press release. Kumar said a centre of excellence will be started in the institute. “Apart from imparting studies and conducting research and development in the field of pharma, this institute will also have a centre of excellence for developing new medical devices.”

The Minister also announced government’s plans to set up the first-ever drug discovery centre and a pharma park in Gujarat.


http://www.financialexpress.com/article/healthcare/happening-now/indias-maiden-med-devices-and-pharma-park-to-come-up-in-gujarat/180091/